Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 known ✓ | Q99720 | 7/20 | 0.61 |
| ▸ | GAA known ✓ | P10253 | 1/20 | 0.56 |
| ▸ | CA2 known ✓ | P00918 | 1/20 | 0.46 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 1/20 | 0.56 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.54 |
| ▸ | NEK2 | P51955 | 1/20 | 0.54 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.54 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.54 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.54 |
| ▸ | EP300 | Q09472 | 1/20 | 0.52 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.52 |
| ▸ | KAT8 | Q9H7Z6 | 1/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.46 |
| ▸ | CNR2 | P34972 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL28099546 | 1.00 | SIGMAR1 (0.61) | SIGMAR1MCL1KDM4EGAAMAPT | |
| Hydrochloric Acid SCHEMBL31515359 | 1.00 | SIGMAR1 (0.61) | SIGMAR1MCL1KDM4EGAAMAPT | |
| SCHEMBL29555314 | 0.98 | SIGMAR1 (0.63) | SIGMAR1MCL1KDM4EGAAMAPT | |
| SCHEMBL27737084 | 0.98 | SIGMAR1 (0.63) | SIGMAR1MCL1KDM4EGAAMAPT | |
| SCHEMBL2349 | 0.98 | SIGMAR1 (0.63) | SIGMAR1MCL1KDM4EGAAMAPT | |
| SCHEMBL29364795 | 0.98 | SIGMAR1 (0.63) | SIGMAR1MCL1KDM4EGAAMAPT | |
| Nitrogen SCHEMBL10584896 | 0.96 | SIGMAR1 (0.57) | SIGMAR1MCL1KDM4EGAAMAPT | |
| Hydrogen Sulfide SCHEMBL3359211 | 0.95 | SIGMAR1 (0.61) | SIGMAR1MCL1KDM4EGAAMAPT | |
| SCHEMBL2173531 | 0.95 | SIGMAR1 (0.61) | SIGMAR1MCL1KDM4EGAAMAPT | |
| SCHEMBL2174491 | 0.95 | SIGMAR1 (0.61) | SIGMAR1MCL1KDM4EGAAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112552182-B | New synthesis process of naftifine drug intermediate N-methyl-1-naphthylmethylamine | 杭州新桂实业有限公司 | 2022-10-11 | — | — | CN | claimed |
| CN-112552182-A | New synthesis process of naftifine drug intermediate N-methyl-1-naphthylmethylamine | 杭州新桂实业有限公司 | 2021-03-26 | — | — | CN | claimed |
| CN-115073303-B | Preparation method of terbinafine hydrochloride Z-type isomer | 乐泰药业(兰西)有限公司 | 2025-02-14 | — | — | CN | disclosed |
| CN-112552182-B | New synthesis process of naftifine drug intermediate N-methyl-1-naphthylmethylamine | 杭州新桂实业有限公司 | 2022-10-11 | — | — | CN | disclosed |
| CN-115073303-A | Preparation method of terbinafine hydrochloride Z-type isomer | 乐泰药业(兰西)有限公司 | 2022-09-20 | — | — | CN | disclosed |
| CN-111606811-B | Preparation method of terbinafine hydrochloride | 山东安弘制药有限公司 | 2022-09-06 | — | — | CN | disclosed |
| CN-114105774-A | Preparation method of N-methyl-1-naphthylmethylamine | 河北海力香料股份有限公司 | 2022-03-01 | — | — | CN | disclosed |
| CN-113788761-A | Method and system for refining medical intermediate | 丽江映华生物药业有限公司 | 2021-12-14 | — | — | CN | disclosed |
| CN-108164423-B | Preparation method of naftifine hydrochloride | 福建金山准点制药有限公司 | 2021-07-13 | — | — | CN | disclosed |
| CN-112552182-A | New synthesis process of naftifine drug intermediate N-methyl-1-naphthylmethylamine | 杭州新桂实业有限公司 | 2021-03-26 | — | — | CN | disclosed |
| CN-111606811-A | Preparation method of terbinafine hydrochloride | 山东安弘制药有限公司 | 2020-09-01 | — | — | CN | disclosed |
| US-6110858-A | AN OLEFIN POLYMERIZATION CATALYST CONSISTS OF A TRANSITION METAL COMPOUND, A MODIFIED CLAY COMPOUND CONTAINING CLAY MINERAL AND AN AMINE COMPOUND AND AN ORGANOALUMINUM COMPOUND | TOSOH CORPORATION (JP) | 2000-08-29 | — | — | US | disclosed |
| US-6034187-A | Catalyst for olefin polymerization and process for production of olefin polymer | TOSOH CORPORATION (JP) | 2000-03-07 | — | — | US | disclosed |
| US-5906955-A | Catalyst for polymerization of an olefin, and method for producing an olefin polymer | TOSOH CORPORATION (JP) | 1999-05-25 | — | — | US | disclosed |
| EP-0881232-A1 | Catalyst for olefin polymerization and process for production of olefin polymer | TOSOH CORPORATION (JP) | 1998-12-02 | — | — | EP | disclosed |
| EP-0849292-A1 | Olefin polymerisation catalysts and processes for producing olefin polymers | TOSOH CORPORATION (JP) | 1998-06-24 | — | — | EP | disclosed |
| EP-0849288-A1 | Catalyst for polymerization of an olefin, and method for producing an olefin polymer | TOSOH CORPORATION (JP) | 1998-06-24 | — | — | EP | disclosed |
| EP-0609625-A1 | Inhibitors of HIV protease useful for the treatment of AIDS | ELI LILLY AND COMPANY (US) | 1994-08-10 | — | — | EP | disclosed |
| US-4822822-A | FUNGICIDES FOR PLANTS AND ANIMALS | MITSUI TOATSU CHEMICALS, INC. (JP) | 1989-04-18 | — | — | US | disclosed |
| EP-0221781-A2 | Benzylamine derivatives, process for production thereof, and use thereof | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1987-05-13 | — | — | EP | disclosed |